ClinVar Miner

Submissions for variant NM_000168.6(GLI3):c.4317C>A (p.Tyr1439Ter) (rs1562656975)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000760565 SCV000890456 likely pathogenic not provided 2018-05-31 criteria provided, single submitter clinical testing The Y1439X variant in the GLI3 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is predicted to cause loss of normal protein function through protein truncation, as the last 142 amino acids of the protein are lost. The Y1439X variant is not observed in large population cohorts (Lek et al., 2016). We interpret Y1439X as a likely pathogenic variant.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.